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Radiation safety is important.
Radiation exposure can lead to stochastic and non-
stochastic injuries.
Knowledge regarding radiation safety is lacking.
Radiation safety practices are not according to
recommendations.
Radiation protection devices are not routinely available
everywhere.
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Abstract
Objective: To evaluate the primary drug resistance of new culture positive cases of pulmonary tuberculosis in
Karachi.
Methods: All new suspected pulmonary tuberculosis patients were recruited initially. They were instructed to
produce three-sputum samples for smear examination and on one of the specimen's culture was applied.
Bronchoscopy and bronchial wash was done in patients who were not expectorating. Bronchial wash was then
applied for both smear and culture for mycobacterium tuberculosis.
Results: Out of 79 cases recruited initially, 52 were able to produce sputum while bronchoscopy was performed
in the remaining. AFB direct smear was positive in 32/52 sputum and 12/27 bronchial wash samples. Later, 02
sputums and 04 bronchial washes became culture positive which were initially smear negative. All cultures were
of Mycobacterium tuberculosis species. These fifty culture positive cases were then included in the final analysis. 
Pyrazinamide was the most sensitive drug i.e. 49 isolates (98%). The resistance pattern is as follows:
Streptomycin 13(26%), Isoniazid 08 (16%), Ethambutol 08 (16%), Rifampicin 04 (08%) and Pyrazinamide one
(02%). Multi-Drug Resistant tuberculosis was observed in 02 (04%) patients.
Conclusion: In this small study, the high prevalence of primary resistance against streptomycin, INH and
Ethambutol raises an urgent need of a proper nationwide survey to evaluate the true picture of primary resistance
(JPMA 58:122;2008)
Introduction
In Pakistan, tuberculosis constitutes a major public
health problem and its incidence is rising due to multi-
factorial reasons including poverty, ignorance, over the
counter sale of anti-tuberculosis drugs and availability of
poor quality medications. Globally Pakistan has been
ranked 7th in terms of estimated number of cases by WHO,
Vol. 58, No. 3, March 2008 122
with an incidence of 181/100,000 persons.1
The data on resistant tuberculosis is sparse from
Pakistan and for the successful control of tuberculosis there
is a need to have regular surveillance of resistance pattern in
the community.  The aim of the study was to evaluate the
present scenario of primary drug resistance of new cases of
pulmonary tuberculosis in Karachi. This study will have an
impact on management guidelines.
Patients and Methods
This study was conducted from October 2004 to
August 2005 at pulmonary section, Department of
Medicine, Aga Khan University Hospital, Karachi. Karachi
is the largest metropolis of Pakistan with a population of
more than 11 million. Aga Khan Hospital (AKH) is a 600-
bedded tertiary care teaching hospital located in Karachi,
Pakistan. The hospital and laboratory are accredited with
Joint Commission of International Accreditation (JCIA).
Laboratory is routinely participating in external quality
control surveys with College of American pathologists
(CAP) sine 1992. The number of patients seen in
Pulmonology outpatient clinics exceeds 14,000 per year. 
Cases were enrolled from the pulmonary clinics of
Aga Khan University Hospital (AKUH). Majority of the
recruited patients were from middle and low socio-
economic group. All patients have full access to over the
counter sale of anti-TB drugs. 
Patients with suspected pulmonary tuberculosis on
clinical and radiological grounds were recruited initially. In
this study none of the recruited patients purchased the ATT
(Anti-tuberculosis treatment) over the counter, which was
specifically inquired, and patients with past history of ATT
were excluded. Assurance was made that they were new
cases and had never received anti-tuberculosis treatment in
the past. 
The recruited subjects were instructed to produce
three-sputums sample for AFB (Acid fast bacilli) smear
examination and on one of the specimen culture was
applied. Bronchoscopy and bronchial wash was done in
patients who were not expectorating. Bronchial wash was
then applied for both smear and culture of mycobacterium
tuberculosis.
All samples were decontaminated with N-acetyl-L-
cysteine (NALC) sodium hydroxide according to standard
protocol. The sediments were used for AFB microscopy and
culture.
Smears for microscopy were screened using
Auramine Rhodamine staining, positive slides were further
confirmed by staining with Kinyoun modification of Ziehl-
Neelson stain.
For TB cultures, LJ and MGIT (Becton Dickinson)
were used. For LJ slant 0.1 ml of concentrated specimen
was inoculated and incubated for 8 weeks. Suspected
colonies were identified on the basis of conventional tests.
Specimens in BACTEC and MGIT were inoculated as per
manufacturer's recommendations.
Antimicrobial susceptibility for anti tuberculosis
drugs except Pyrazinamide tested using modified agar
proportion method according to Clinical Laboratory
Standards Institute (CLSI). Pyrazinamide was tested using
BACTEC 12B according to manufacturer's
recommendations.
MTB H37Rv was used as control with each batch of
susceptibility testing.
In the final analysis, only culture positive cases for
M. tuberculosis were included.
Results
A total of 79 cases were recruited initially. Fifty-two
were able to produce sputum while bronchoscopy was
performed in the remaining. AFB direct smear was positive
in 32/52 sputums and 12/27 bronchial wash samples. AFB
direct smear was positive in 32 sputum samples while 12/27
bronchial wash samples were also positive. Later, 02
sputum and 04 bronchial washes specimens turned out
culture positive, which were initially smear negative. All
cultures were of Mycobacterium tuberculosis species. These
fifty culture positive cases were then included in the final
analysis.
There were 33 male and 17 female with median age
of 33 years (range 15-55 years). The commonest
presentations were cough (100%), fever (68%), sputum
(64%) and tiredness (58%). 
Table shows the resistance against first line drugs.
Sensitivity against Rifamycin was available in 44 patients
and all isolates were sensitive. MDR was seen in 02(04%).
Twenty-five (50%) isolates were sensitive to all five
drugs. 18/50(36%) were resistant to one drug, 05/50 (10%)
were resistant to two drugs and 02/50 (04%) were resistant
to three drugs. The latter group was also resistant against
Rifampicin and Isoniazid i.e. Multi-Drug Resistant
tuberculosis (MDR-TB). Not a single isolate was resistant
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against both streptomycin and Isoniazid.
Discussion
This study has shown significant resistance against
first line drugs. The resistance against streptomycin is
highest (26%), followed by INH (Isonicotinic acid
hydrazide) and Ethambutol (16% each). This high
resistance is alarming and could be due to the use of these
drugs for a longer duration. Other reasons could be erratic
prescriptions by health care providers, manipulation of
medications by the patients, increase use of INH and
Ethambutol in the continuation phase and indiscriminate
use of streptomycin by General Practitioners and health care
providers for conditions other than tuberculosis. 
The locally reported data2-4 about resistance against
INH (13.3 to 16%) correlates with our study.  Sadique and
Suhail2,3 have reported low resistance against Ethambutol
(Zero%) and Streptomycin (3.7&11%), which is unreliable
because of small sample size in their study. It is
recommended that to determine low resistance rate,
surveillance of large sample size is needed i.e. 300-600
specimens.5
In this study, the resistance against one or more first
line drugs is 50% which is high in comparison to the
reported 17% and 24% by Khan J6 (1993) and Rano Mal et
al4 (2000) respectively. Both of these reported studies were
done in Karachi so it seems likely to represent the same
population. Sohail Akhtar7 from Karachi reported primary
and initial resistance to at least one drug by 7% and 21%
respectively. 
Shamshad R8 from Lahore reported 52.16%
resistance to one or more first line drugs that is comparable
to our study. When comparing this study with Rano Mal et
al, mono-resistance was 39% v/s 20%, resistance against
two drugs was 10% v/s 04% and resistance against three
drugs was zero v/s 04%. MDR (Multi-Drug Resistant)
tuberculosis was 04% v/s 01%. These entire figures suggest
an increasing trend in resistance.
The trend in resistance pattern against INH remains
static since 19936 while resistance against Rifampicin has
increased in the same period from 03% to 08%.
Interestingly the resistance against Rifampicin is static since
2000.2-4
The data from our neighboring country India9 is
similar as far as resistance against streptomycin and INH is
concerned i.e. 7.2-12.4% and 15.2-23.4% respectively.
They reported low resistance against Ethambutol 01-4.6%
and Rifampicin 0.5 - 2.8% in comparison to our study.  
The data from remaining parts of the world9 reveal
highest primary resistance against streptomycin i.e. 21.7%
to 44.3% from Lithuania and Uzbekistan respectively. The
findings are similar to our study. The reported resistance
against INH from China (Henan), Turkmenstan and
Mongolia are similar to our results i.e. 17%, 15.2%
and15.3% respectively while Kazakhstan have shown
highest resistance (42.6%). The resistance against
Ethambutol is lesser than China, Turkmenistan, Egypt and
Mangolia ie from 1.7 to 4.3. Higher rates were reported
from Estonia, Uzbekistan and Kazakhstan (13.2 to 24.8%).
The resistance against Rifampicin varies between 1.2 and
15.6% from Mangolia and Kazakhstan. In this report9,
sensitivity against Pyrazinamide is not done.
The MDR tuberculosis in this study is 4%. Sohail
Akhtar7 in his series (January 1999 to March 2003) reported
zero MDR case while Rizwan et al10 from Lahore reported
12% primary MDR. Recently Seema et al11 from Karachi
(January - September 2004) reported 10% primary MDR.
In other parts of the world8 the reported MDR tuberculosis
ranged 9.3%, 10.4%, 12.2%, 13.2% and 14.2% from Latvia,
Liaoning, China, Estonia, Uzbekistan and Kazakhstan
respectively. In India it is 0.5-2.8%.9
The possible reasons for the increase in resistance in
our country are poor compliance, ignorance on the part of
patients, over the counter sale of anti-tuberculosis drugs,
poor quality anti-TB drugs, unpredictable supply of anti-TB
drugs in public hospitals and non-standardized regimens.
Masroor et al12 reported that low socioeconomic status,
improper dose schedule, under dosage and lack of health
education apparently seemed to be responsible for most
cases of drug resistance. Ziaullah et al13 reported his drug-
resistant cases to be among low socioeconomic status
people. He added that ninety-five percent of cases had a
history of treatment at least once, hence concluded that the
resistance was of acquired type.
It has been reported9 that Pakistan has achieved
100% DOTS (Directly Observed Treatment Short course)
coverage in public sector in May 2005 heading towards a
hope for controlling TB. But at the same time there is a need
to involve Private Practitioners with the Provincial TB
Control Program (Public Private Partnership) in an
organized line14 because it is estimated that from amongst
the TB patients seeking treatment approximately 80%
initially report to their private practitioners for their
diagnosis and treatment.15
The weaknesses of this study are: small sample size,
hospital-based study and lack of a reference laboratory. 
Conclusion
There is high prevalence of primary resistance
against streptomycin, INH and Ethambutol. The small
sample size could not allow generalizing these results.
Vol. 58, No. 3, March 2008 124
There is an urgent need to evaluate nationwide primary
resistance pattern so that strategy in the treatment of
tuberculosis be planned especially the use of Ethambutol
and INH in the continuation phase of category-I treatment.   
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Causes of amblyopia in children coming to ophthalmology out patient department
Khyber Teaching Hospital, Peshawar
Sadia Sethi1, Mohammad Junaid Sethi2, Ibrar Hussain3, Naimatullah Khan Kundi4
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Abstract
Objective: To find the causes of amblyopia in patients 4 to 14 years old attending out patient Ophthalmology
department of Khyber teaching Hospital Peshawar. 
Methods: In this prospective cohort hospital based study 200 children aged 4-14 years were studied over a
period of 12 months from December 2005 to November 2006 in outpatient department of Ophthalmology, Khyber
Teaching Hospital. Visual acuity was checked with Snellen's and Lea symbols depending on level of cooperation
of patient. Cycloplegic refraction and orthoptic assessment was performed on all patients. Amblyopia was
classified as strabismic, anisometropic, combined and stimulus deprivation. Treatment consisted of optical
correction, patching, atropinization and surgery.
Results: Out of 200 patients 126(63%) were male and 74 (37%) were female, 114 (57%) were in age group 4-
9 years while 86 (43%) were between 10-14 years. Strabismic amblyopia was present in 110 (55%),
Anisometropic amblyopia in 42 (21%), combined mechanism amblyopia in 32 (16%), ammetropia in 12 (6%) and
stimulus deprivation amblyopia in 4 (2%) Binocularity could not be assessed in 16 (8%), was present in 38 (19%)
and absent in 148 (73%).
Conclusion: Amblyopia was more common in males than females. Most of the children presented in younger
age group of 4-9 years. Strabismic amblyopia was the most common cause of amblyopia. Amblyopia was more
common in esotropes than exotropes. Half of the patients had moderate amblyopia, while the remaining were
suffering from either mild or severe amblyopia. Binocularity was absent in 73% of the patients (JPMA
58:125;2008).
Introduction
Amblyopia is classically defined as a reduction in
corrected visual acuity (VA) in absence of visible organic
abnormalities and is due to misdirected, blurred, or
absent retinal images during development of visual
system.1 It is the most frequent cause of monocular
visual impairment in both young and adults.2 The causes 
of amblyopia include strabismus, anisometropia, high
refractive error, media opacities, high astigmatism or
combination of two or more etiologies in the same
patient. Strabismic amblyopia is the most common form
of amblyopia which develops in consistently deviating
eye of the child with ocular misalignment. Constant or
alternate tropias (typically esodeviations) are most likely 
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